X
09Oct

Caremark Round II: Beware Red Flags in Drug Development

Goodwin | | Return|
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/

Related

El Tio Tex-Mex Grill to Pay $40,000 to Settle EEOC Harassment Lawsuit

Virginia Eatery Routinely Subjected Gay Male Server and His Straight Friend to Homophobic Taunts and...

Read More >

U.S. Supreme Court Holds Plaintiffs Need Actual Knowledge Of Breach Of Fiduciary Duty To Be Held To Three-Year Statute Of Limitations Under ERISA

On February 26, 2020, the United States Supreme Court, in a unanimous decision by Justice Samuel Ali...

Read More >

SEC Amends Disclosure Requirements for Guaranteed Securities

The amendments will become effective on January 4, 2021, with earlier compliance permitted. The ame...

Read More >

California issues draft guidance for vapor intrusion to indoor air

California environmental agencies recently issued a draft vapor intrusion guidance document that wil...

Read More >

[Virtual Event] 2021 Middle East and Africa Regional Compliance & Ethics Conference - February 11th, 8:55 am - 2:00 pm GST

Our Virtual Regional Compliance Conferences provide updates on the latest news in regulatory require...

Read More >

Littler Global Guide - Portugal - Q2 2019

The Creation of the Contract-Generation Measure Introduces New Incentives for Hiring - New Legislat...

Read More >